Skip to content
    CLRB stock page

    Cellectar Biosciences, Inc.

    CLRB · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 13, 2026

      Cellectar Biosciences Q2 FY26 — Iopopacin WM Confirmatory Study Initiated, Mid-2027 NDA Target

      Read the brief

    Browse all US companies on the earnings-call register.